Honestly screw these people trying to barter out after they tried to lowball us. I would rather LNK gave these guys a middle finger and continue with the in-species distribution of PEXA. There is no reason for the core LNK price (after taking out PXA value) to be trading at a PE of roughly 7 to 8 currently. The core business is profitable and hedge positively to interest rate increases.
This is stupid, give me my Pexa shares and let core LNK rerate...
- Forums
- ASX - By Stock
- LNK
- Ann: Update on Scheme
Ann: Update on Scheme
Featured News
Add LNK (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online